Lei Fang
Corporate Officer/Principal at LEPU BIOPHARMA CO., LTD.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ziye Sui | M | - |
CtM Bio Co., Ltd.
| 4 years |
Feng Mao Hua | M | 56 | 3 years | |
Zhong Jie Pu | M | 61 | 6 years | |
De Min Zhou | M | 58 | 4 years | |
Hai Feng Yang | M | 47 | 4 years | |
Yun Yi Li | F | 44 | 4 years | |
Yang Xu | M | 57 | 4 years | |
Siu Kuen Lai | F | 48 | 3 years | |
Ming Yang | M | 58 | 4 years | |
Jue Pu | M | 34 | 4 years | |
Jiwei Wang | M | 37 | 4 years | |
Hongbing Yang | M | 55 | 4 years | |
Min MIn Qin | M | 66 | 4 years | |
Hu Li | M | 59 | 4 years | |
Maggie Geman Li | F | 58 | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Yi Peng Li | M | 47 | - | |
Chao Hong Hu | M | 58 | 4 years | |
Xiang Hong Lin | M | 53 | 4 years | |
Qian Liu | F | 42 |
Hebei University
| 4 years |
Pei Rui Sun | M | 41 |
Hebei University
| 4 years |
Hui Yan You | F | 41 |
Hebei University
| 3 years |
Ming Yu Li | M | 41 |
Hebei University
| 4 years |
Ya Jing Pang | M | 39 |
Hebei University
| 4 years |
Tao Feng | M | 43 |
Hebei University
| 4 years |
Fredrick Hausheer | M | 68 | 2 years | |
Alan Au | M | - |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | - |
Jing Yang | F | 44 |
Hebei University
| 4 years |
Xiang Yan | M | 65 |
Hebei University
| 1 years |
Jianhai Xu | M | 39 |
Hebei University
| 4 years |
Lian Zhi Li | F | 41 |
Hebei University
| 4 years |
Yang Yangqing | M | 42 |
Hebei University
| 4 years |
Bao Cheng Zhu | M | 51 |
Hebei University
| 1 years |
Jie Lun Zhu | M | 48 |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | - |
Feng Liu | M | 42 |
Hebei University
| 4 years |
Hui Shi | M | 41 |
Hebei University
| 4 years |
Hong Wei Liu | M | 41 |
Hebei University
| 3 years |
Hai Chao Zhang | M | 47 |
Hebei University
| 4 years |
Jin Long Zhang | M | 42 |
Hebei University
| 3 years |
Zhi Wei Liu | F | 43 |
Hebei University
| 4 years |
Michael Keyoung | M | 50 |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | 3 years |
Yong Tian Wang | M | 43 |
Hebei University
| 4 years |
Qianli Hua | M | 45 |
Hebei University
| 4 years |
Bao Hou Yi | M | 61 |
Hebei University
| 1 years |
Yan Po Jiao | M | 43 |
Hebei University
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
China | 44 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lei Fang
- Personal Network